Invention Grant
- Patent Title: Targeting pleiotrophin signaling to limit high-grade glioma invasion
-
Application No.: US15998437Application Date: 2018-08-15
-
Publication No.: US10550388B2Publication Date: 2020-02-04
- Inventor: Michelle Monje-Deisseroth , Elizabeth Qin
- Applicant: The Board of Trustees of the Leland Stanford Junior University
- Applicant Address: US CA Stanford
- Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee Address: US CA Stanford
- Agency: Bozicevic, Field & Francis LLP
- Agent Jenny L. Buchbinder
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/4439 ; A61K31/5377 ; A61K31/7105 ; A61K31/713 ; A61K9/08 ; A61P35/00 ; A61K45/06 ; A61K9/00
Abstract:
Compositions and methods for treatment of glioma are disclosed. In particular, the invention relates to methods of treating glioma by inhibiting pleiotrophin signaling to limit high-grade glioma invasion.
Public/Granted literature
- US20190055556A1 Targeting pleiotrophin signaling to limit high-grade glioma invasion Public/Granted day:2019-02-21
Information query
IPC分类:
